ArticleProbiotics and antimicrobial proteins2026
Recombinant Bacillus subtilis Displaying DHAV-1 VP1 Protein as a Dual-Function Probiotic: Evaluation of Immunological Efficacy, Growth Performance, Antioxidant Capacity, and Intestinal Health in Cherry Valley Ducks.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Duck hepatitis A virus type 1 (DHAV-1) demonstrates extremely high lethality in 3-week-old ducklings, while causing subclinical infections in adult ducks with latent pathogenicity. Our previous research developed a vaccine-functional probiotic preparation targeting DHAV-1-recombinant Bacillus subtilis RV. In the present study, we conducted a 28-day oral immunization trial in Cherry Valley ducks to evaluate the immunoprotective effects and probiotic functions of this engineered strain. Results showed that B. subtilis RV induced humoral and mucosal immune responses in ducklings, producing high levels of specific IgG and intestinal secretory IgA, demonstrating immune-enhancing capabilities. During DHAV-1 challenge tests, it significantly reduced viral loads in various organ tissues. Additionally, B. subtilis RV improved the growth performance and antioxidant capacity of ducklings. Furthermore, this engineered probiotic enhanced intestinal health by improving intestinal structure, increasing tight junction protein expression, and modulating gut microbiota composition. This study evaluates a novel vaccine-functional probiotic preparation, providing a new strategy for DHAV-1 prevention and control.
Indexed as
Identifiers
40815365What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.